Contra Acer Therapeutics
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Contra Acer Therapeutics in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Thompson Investment Management, Inc. ($0).
- Company
- Contra Acer Therapeutics
- CUSIP
- 004CVR049
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Thompson Investment Management, Inc. | 0.00% | No change | 10 | $0 |
"% of holder's portfolio" is CONTRA ACER THERAPEUTICS's weight in each manager's 13F, not the share of Contra Acer Therapeutics the manager owns.